| 1 |
27063220 | An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s. | 2016 May |
1 |
| 2 |
24117377 | Cytochrome P450 modified polycrystalline indium tin oxide film as a drug metabolizing electrochemical biosensor with a simple configuration. | 2013 Nov 5 |
1 |
| 3 |
17484519 | Identification of human cytochrome P450 enzymes involved in the major metabolic pathway of fluvoxamine. | 2007 Feb |
1 |
| 4 |
15537169 | The in vitro metabolism of desglymidodrine, an active metabolite of prodrug midodrine by human liver microsomes. | 2004 Jul-Sep |
1 |
| 5 |
10381752 | Activation of human cytochrome P-450 3A4-catalyzed meloxicam 5'-methylhydroxylation by quinidine and hydroquinidine in vitro. | 1999 Jul |
1 |
| 6 |
8654202 | Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride. | 1995 Oct |
1 |
| 7 |
8408733 | Evaluation of the pharmacokinetic and pharmacodynamic interaction between quinidine and nifedipine. | 1993 Aug |
1 |
| 8 |
2312782 | Quinidine does not alter antipyrine metabolism. | 1990 Mar |
2 |
| 9 |
2357863 | Quinidine reduces clearance of (+)-propranolol more than (-)-propranolol through marked reduction in 4-hydroxylation. | 1990 Jun |
1 |
| 10 |
2894945 | In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver. | 1988 Jan-Feb |
1 |
| 11 |
3689440 | Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiency. | 1987 Dec 1 |
1 |
| 12 |
3748010 | Oxidation of quinidine by human liver cytochrome P-450. | 1986 Sep |
1 |